Clinical Trial Update: A Long Term Follow-up Study of TScan TCR-T Products

View source ↗

Summary

This clinical trial update describes a long-term follow-up study of TScan Therapeutics' TCR-T cell therapies for acute myeloid leukemia, acute lymphoblastic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• TScan TCR-T cell therapy (TCR-T cell therapy)

Snippet

Sponsor: TScan Therapeutics, Inc. | Conditions: AML, ALL | Status: RECRUITING